Navigation Links
LMS integrated obstetrics solution achieves general availability
Date:9/24/2007

MONTREAL, Sept. 24 /PRNewswire-FirstCall/ - LMS Medical Systems (AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer of the CALM(R) clinical information system and risk management software for obstetrics, today announced that Horizon Perinatal Care(TM), the first obstetrics (OB)/perinatal information system designed to support continuity of care between the labor and delivery (L&D) department and other hospital departments and units, developed in conjunction with McKesson Provider Technologies, has become generally available in the marketplace.

Horizon Perinatal Care seamlessly integrates with McKesson's enterprise clinical systems to provide ready access to historical patient information and eliminate redundant charting in support of providing safer, more efficient care to baby and mother. The integrated solution combines fetal strip archival and surveillance capabilities with McKesson's Horizon Clinicals(R) suite of solutions that are used in obstetrical care such as enterprise clinical history and interventions, documentation and bar-code medication administration.

"This milestone is the result of a joint development effort on the part of many dedicated people at both companies," said Diane Cote, President and CEO of LMS. "Bringing the product to life with LMS obstetrical solutions will mean safer deliveries for expectant mothers while providing clinicians a simpler, much needed system within which to work."

About LMS: LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM Suite provides physicians, nursing staff, risk managers and hospital administrators with OB clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth.

Horizon Perinatal Care is a trademark of McKesson.

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed implied by the forward-looking statements including, but without limitation, economic conditions in general and in the healthcare market, the demand for and market for our products in domestic and international markets, our current dependence on the CALM product suite, the challenges associated with developing new products and obtaining regulatory approvals if necessary, research and development activities, the uncertainty of acceptance of our products by the medical community, the lengthy sales cycle for our products, third party reimbursement, competition in our markets, including the potential introduction of competitive products by others, our dependence on our distributors, physician training, enforceability and the costs of enforcement of our patents, potential infringements of our patents and the other factors set forth from time to time in the Company's filings with the United States Securities and Exchange Commission and with the Canadian Securities Commissions. The Company has no intention of or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE LMS MEDICAL SYSTEMS INC.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Integrated Disease Surveillance Project Soon In The Country
2. Integrated Child Development Scheme
3. Mumbai to Have Integrated Trauma Care Facility
4. Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models
5. Integrated Trauma Care Facility in Mumbai
6. Negligence Cases in the Obstetrics Department Increases Fatality Rates
7. Malpractice Worry Discouraging Medical Students From Taking Up Obstetrics And Gynecology
8. Half a Million Dollars Offered for GPs With Expertise in Anesthetics and Obstetrics
9. TIZANIDINE - New solution to chronic headache
10. A Solution To Quit Smoking Without Gaining Weight
11. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: